| Year |
Citation |
Score |
| 2009 |
Kabingu E, Oseroff AR, Wilding GE, Gollnick SO. Enhanced systemic immune reactivity to a Basal cell carcinoma associated antigen following photodynamic therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 4460-6. PMID 19549769 DOI: 10.1158/1078-0432.Ccr-09-0400 |
0.336 |
|
| 2009 |
Pandey SK, Sajjad M, Chen Y, Pandey A, Missert JR, Batt C, Yao R, Nabi HA, Oseroff AR, Pandey RK. Compared to purpurinimides, the pyropheophorbide containing an iodobenzyl group showed enhanced PDT efficacy and tumor imaging (124I-PET) ability. Bioconjugate Chemistry. 20: 274-82. PMID 19191565 DOI: 10.1021/Bc8003638 |
0.583 |
|
| 2009 |
Pandey SK, Sajjad M, Chen Y, Zheng X, Yao R, Missert JR, Batt C, Nabi HA, Oseroff AR, Pandey RK. Comparative positron-emission tomography (PET) imaging and phototherapeutic potential of 124I- labeled methyl- 3-(1'-iodobenzyloxyethyl)pyropheophorbide-a vs the corresponding glucose and galactose conjugates. Journal of Medicinal Chemistry. 52: 445-55. PMID 19090663 DOI: 10.1021/Jm8012213 |
0.602 |
|
| 2007 |
Chen Y, Ohkubo K, Zhang M, Wenbo E, Liu W, Pandey SK, Ciesielski M, Baumann H, Erin T, Fukuzumi S, Kadish KM, Fenstermaker R, Oseroff A, Pandey RK. Photophysical, electrochemical characteristics and cross-linking of STAT-3 protein by an efficient bifunctional agent for fluorescence image-guided photodynamic therapy. Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society For Photobiology. 6: 1257-67. PMID 18046480 DOI: 10.1039/B710395F |
0.59 |
|
| 2007 |
Gryshuk A, Chen Y, Goswami LN, Pandey S, Missert JR, Ohulchanskyy T, Potter W, Prasad PN, Oseroff A, Pandey RK. Structure-activity relationship among purpurinimides and bacteriopurpurinimides: trifluoromethyl substituent enhanced the photosensitizing efficacy. Journal of Medicinal Chemistry. 50: 1754-67. PMID 17371002 DOI: 10.1021/Jm061036Q |
0.41 |
|
| 2006 |
Pandey RK, Goswami LN, Chen Y, Gryshuk A, Missert JR, Oseroff A, Dougherty TJ. Nature: a rich source for developing multifunctional agents. Tumor-imaging and photodynamic therapy. Lasers in Surgery and Medicine. 38: 445-67. PMID 16788930 DOI: 10.1002/Lsm.20352 |
0.615 |
|
| 2006 |
Bellnier DA, Greco WR, Loewen GM, Nava H, Oseroff AR, Dougherty TJ. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX. Lasers in Surgery and Medicine. 38: 439-44. PMID 16634075 DOI: 10.1002/lsm.20340 |
0.413 |
|
| 2006 |
Gryshuk AL, Chen Y, Potter W, Ohulchansky T, Oseroff A, Pandey RK. In vivo stability and photodynamic efficacy of fluorinated bacteriopurpurinimides derived from bacteriochlorophyll-a. Journal of Medicinal Chemistry. 49: 1874-81. PMID 16539373 DOI: 10.1021/Jm050919Z |
0.538 |
|
| 2006 |
Rosenfeld A, Morgan J, Goswami LN, Ohulchanskyy T, Zheng X, Prasad PN, Oseroff A, Pandey RK. Photosensitizers derived from 132-oxo-methyl pyropheophorbide-a: enhanced effect of indium(III) as a central metal in in vitro and in vivo photosensitizing efficacy. Photochemistry and Photobiology. 82: 626-34. PMID 16277564 DOI: 10.1562/2005-09-29-Ra-704 |
0.402 |
|
| 2005 |
Pandey SK, Gryshuk AL, Sajjad M, Zheng X, Chen Y, Abouzeid MM, Morgan J, Charamisinau I, Nabi HA, Oseroff A, Pandey RK. Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible "see and treat" approach. Journal of Medicinal Chemistry. 48: 6286-95. PMID 16190755 DOI: 10.1021/Jm050427M |
0.712 |
|
| 2005 |
Chen Y, Gryshuk A, Achilefu S, Ohulchansky T, Potter W, Zhong T, Morgan J, Chance B, Prasad PN, Henderson BW, Oseroff A, Pandey RK. A novel approach to a bifunctional photosensitizer for tumor imaging and phototherapy. Bioconjugate Chemistry. 16: 1264-74. PMID 16173807 DOI: 10.1021/Bc050177O |
0.776 |
|
| 2005 |
Seshadri M, Spernyak JA, Mazurchuk R, Camacho SH, Oseroff AR, Cheney RT, Bellnier DA. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4241-50. PMID 15930363 DOI: 10.1158/1078-0432.Ccr-04-2703 |
0.511 |
|
| 2005 |
Li G, Slansky A, Dobhal MP, Goswami LN, Graham A, Chen Y, Kanter P, Alberico RA, Spernyak J, Morgan J, Mazurchuk R, Oseroff A, Grossman Z, Pandey RK. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy. Bioconjugate Chemistry. 16: 32-42. PMID 15656573 DOI: 10.1021/Bc049807X |
0.75 |
|
| 2004 |
Chen Y, Sumlin A, Morgan J, Gryshuk A, Oseroff A, Henderson BW, Dougherty TJ, Pandey RK. Synthesis and photosensitizing efficacy of isomerically pure bacteriopurpurinimides. Journal of Medicinal Chemistry. 47: 4814-7. PMID 15369384 DOI: 10.1021/Jm049630S |
0.316 |
|
| 2003 |
Li G, Graham A, Chen Y, Dobhal MP, Morgan J, Zheng G, Kozyrev A, Oseroff A, Dougherty TJ, Pandey RK. Synthesis, comparative photosensitizing efficacy, human serum albumin (site II) binding ability, and intracellular localization characteristics of novel benzobacteriochlorins derived from vic-dihydroxybacteriochlorins. Journal of Medicinal Chemistry. 46: 5349-59. PMID 14640543 DOI: 10.1021/Jm030341Y |
0.462 |
|
| 2003 |
Graham A, Li G, Chen Y, Morgan J, Oseroff A, Dougherty TJ, Pandey RK. Structure-activity relationship of new octaethylporphyrin-based benzochlorins as photosensitizers for photodynamic therapy. Photochemistry and Photobiology. 77: 561-6. PMID 12812301 DOI: 10.1562/0031-8655(2003)077<0561:Sronob>2.0.Co;2 |
0.364 |
|
| 2003 |
Pandey SK, Gryshuk AL, Graham A, Ohkubo K, Fukuzumi S, Dobhal MP, Zheng G, Ou Z, Zhan R, Kadish KM, Oseroff A, Ramaprasad S, Pandey RK. Fluorinated photosensitizers: synthesis, photophysical, electrochemical, intracellular localization, in vitro photosensitizing efficacy and determination of tumor-uptake by 19F in vivo NMR spectroscopy Tetrahedron. 59: 10059-10073. DOI: 10.1016/J.Tet.2003.10.016 |
0.528 |
|
| 2002 |
Gryshuk AL, Graham A, Pandey SK, Potter WR, Missert JR, Oseroff A, Dougherty TJ, Pandey RK. A first comparative study of purpurinimide-based fluorinated vs. nonfluorinated photosensitizers for photodynamic therapy. Photochemistry and Photobiology. 76: 555-9. PMID 12462653 DOI: 10.1562/0031-8655(2002)076<0555:Afcsop>2.0.Co;2 |
0.342 |
|
| 2002 |
Hilmey DG, Abe M, Nelen MI, Stilts CE, Baker GA, Baker SN, Bright FV, Davies SR, Gollnick SO, Oseroff AR, Gibson SL, Hilf R, Detty MR. Water-soluble, core-modified porphyrins as novel, longer-wavelength-absorbing sensitizers for photodynamic therapy. II. Effects of core heteroatoms and meso-substituents on biological activity. Journal of Medicinal Chemistry. 45: 449-61. PMID 11784149 DOI: 10.1021/Jm0103662 |
0.311 |
|
| 2002 |
Chen Y, Graham A, Potter W, Morgan J, Vaughan L, Bellnier DA, Henderson BW, Oseroff A, Dougherty TJ, Pandey RK. Bacteriopurpurinimides: highly stable and potent photosensitizers for photodynamic therapy. Journal of Medicinal Chemistry. 45: 255-8. PMID 11784129 DOI: 10.1021/Jm010400C |
0.31 |
|
| 2001 |
Li G, Graham A, Potter W, Grossman ZD, Oseroff A, Dougherty TJ, Pandey RK. A simple and efficient approach for the synthesis of fluorinated and nonfluorinated octaethylporphyrin-based benzochlorins with variable lipophilicity, their in vivo tumor uptake, and the preliminary in vitro photosensitizing efficacy Journal of Organic Chemistry. 66: 1316-1325. PMID 11312962 DOI: 10.1021/Jo001541+ |
0.477 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2007 |
Liu W, Baer MR, Bowman MJ, Pera P, Zheng X, Morgan J, Pandey RA, Oseroff AR. The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2463-70. PMID 17438106 DOI: 10.1158/1078-0432.Ccr-06-1599 |
0.278 |
|
| 2003 |
Roy I, Ohulchanskyy TY, Pudavar HE, Bergey EJ, Oseroff AR, Morgan J, Dougherty TJ, Prasad PN. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy. Journal of the American Chemical Society. 125: 7860-5. PMID 12823004 DOI: 10.1021/Ja0343095 |
0.25 |
|
| 2003 |
Zeitouni NC, Oseroff AR, Shieh S. Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Molecular Immunology. 39: 1133-6. PMID 12835091 |
0.238 |
|
| 2007 |
Pandey SK, Zheng X, Morgan J, Missert JR, Liu TH, Shibata M, Bellnier DA, Oseroff AR, Henderson BW, Dougherty TJ, Pandey RK. Purpurinimide carbohydrate conjugates: effect of the position of the carbohydrate moiety in photosensitizing efficacy. Molecular Pharmaceutics. 4: 448-64. PMID 17373821 DOI: 10.1021/Mp060135X |
0.236 |
|
| 2007 |
Fien SM, Oseroff AR. Photodynamic therapy for non-melanoma skin cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 5: 531-40. PMID 17509255 |
0.236 |
|
| 2004 |
Dobhal MP, Li G, Gryshuk A, Graham A, Bhatanager AK, Khaja SD, Joshi YC, Sharma MC, Oseroff A, Pandey RK. Structural modifications of plumieride isolated from Plumeria bicolor and the effect of these modifications on in vitro anticancer activity. The Journal of Organic Chemistry. 69: 6165-72. PMID 15357574 DOI: 10.1021/Jo0491408 |
0.234 |
|
| 2006 |
Oseroff A. PDT as a cytotoxic agent and biological response modifier: Implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients. The Journal of Investigative Dermatology. 126: 542-4. PMID 16482195 DOI: 10.1038/sj.jid.5700207 |
0.233 |
|
| 2007 |
Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass F, Grekin RC, Grichnik JM, Kessinger A, Lee NY, Lessin S, Lydiatt DD, Margolis LW, ... ... Oseroff AR, et al. Dermatofibrosarcoma protuberans. Journal of the National Comprehensive Cancer Network : Jnccn. 5: 550-5. PMID 17509257 |
0.219 |
|
| 2002 |
Brennan NK, Hall JP, Davies SR, Gollnick SO, Oseroff AR, Gibson SL, Hilf R, Detty MR. In vitro photodynamic properties of chalcogenopyrylium analogues of the thiopyrylium antitumor agent AA1. Journal of Medicinal Chemistry. 45: 5123-35. PMID 12408723 DOI: 10.1021/Jm020260M |
0.216 |
|
| 2004 |
Liu W, Oseroff AR, Baumann H. Photodynamic therapy causes cross-linking of signal transducer and activator of transcription proteins and attenuation of interleukin-6 cytokine responsiveness in epithelial cells. Cancer Research. 64: 6579-87. PMID 15374971 DOI: 10.1158/0008-5472.Can-04-1580 |
0.216 |
|
| 2003 |
You Y, Gibson SL, Hilf R, Davies SR, Oseroff AR, Roy I, Ohulchanskyy TY, Bergey EJ, Detty MR. Water soluble, core-modified porphyrins. 3. Synthesis, photophysical properties, and in vitro studies of photosensitization, uptake, and localization with carboxylic acid-substituted derivatives. Journal of Medicinal Chemistry. 46: 3734-47. PMID 12904078 DOI: 10.1021/Jm030136I |
0.204 |
|
| 2009 |
Foley P, Freeman M, Menter A, Siller G, El-Azhary RA, Gebauer K, Lowe NJ, Jarratt MT, Murrell DF, Rich P, Pariser DM, Oseroff AR, Barnetson R, Anderson C, Kossard S, et al. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies. International Journal of Dermatology. 48: 1236-45. PMID 20064185 DOI: 10.1111/J.1365-4632.2008.04022.X |
0.195 |
|
| 2007 |
Ohulchanskyy TY, Roy I, Goswami LN, Chen Y, Bergey EJ, Pandey RK, Oseroff AR, Prasad PN. Organically modified silica nanoparticles with covalently incorporated photosensitizer for photodynamic therapy of cancer. Nano Letters. 7: 2835-42. PMID 17718587 DOI: 10.1021/Nl0714637 |
0.195 |
|
| 2006 |
Pandey SK, Chen Y, Zawada RH, Oseroff A, Pandey RK. Utility of tumor-avid photosensitizers in developing bifunctional agents for tumor imaging and/or phototherapy Biomedical Optics. 6139: 613905. DOI: 10.1117/12.647866 |
0.187 |
|
| 2003 |
Wong TW, Tracy E, Oseroff AR, Baumann H. Photodynamic therapy mediates immediate loss of cellular responsiveness to cytokines and growth factors. Cancer Research. 63: 3812-8. PMID 12839978 |
0.184 |
|
| 2002 |
Wood LM, Bellnier DA, Oseroff AR, Potter WR. A beam-splitting device for use with fiber-coupled laser light sources for photodynamic therapy. Photochemistry and Photobiology. 76: 683-5. PMID 12511051 DOI: 10.1562/0031-8655(2002)076<0683:ABSDFU>2.0.CO;2 |
0.177 |
|
| 2004 |
Li G, Pandey SK, Graham A, Dobhal MP, Mehta R, Chen Y, Gryshuk A, Rittenhouse-Olson K, Oseroff A, Pandey RK. Functionalization of OEP-based benzochlorins to develop carbohydrate-conjugated photosensitizers. Attempt to target beta-galactoside-recognized proteins. The Journal of Organic Chemistry. 69: 158-72. PMID 14703392 DOI: 10.1021/Jo030280B |
0.17 |
|
| 2005 |
Chen Y, Zheng X, Dobhal MP, Gryshuk A, Morgan J, Dougherty TJ, Oseroff A, Pandey RK. Methyl pyropheophorbide-a analogues: potential fluorescent probes for the peripheral-type benzodiazepine receptor. Effect of central metal in photosensitizing efficacy. Journal of Medicinal Chemistry. 48: 3692-5. PMID 15916419 DOI: 10.1021/Jm050039K |
0.159 |
|
| 2003 |
Bellnier DA, Greco WR, Loewen GM, Nava H, Oseroff AR, Pandey RK, Tsuchida T, Dougherty TJ. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients. Cancer Research. 63: 1806-13. PMID 12702566 |
0.155 |
|
| 2002 |
Johnson PG, Hui SW, Oseroff AR. Electrically enhanced percutaneous delivery of delta-aminolevulinic acid using electric pulses and a DC potential. Photochemistry and Photobiology. 75: 534-40. PMID 12017481 DOI: 10.1562/0031-8655(2002)075<0534:Eepdoa>2.0.Co;2 |
0.129 |
|
| 2006 |
Bellnier DA, Greco WR, Nava H, Loewen GM, Oseroff AR, Dougherty TJ. Mild skin photosensitivity in cancer patients following injection of Photochlor (2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a; HPPH) for photodynamic therapy. Cancer Chemotherapy and Pharmacology. 57: 40-5. PMID 16001178 DOI: 10.1007/s00280-005-0015-6 |
0.115 |
|
| 2006 |
Oseroff AR, Blumenson LR, Wilson BD, Mang TS, Bellnier DA, Parsons JC, Frawley N, Cooper M, Zeitouni N, Dougherty TJ. A dose ranging study of photodynamic therapy with porfimer sodium (Photofrin) for treatment of basal cell carcinoma. Lasers in Surgery and Medicine. 38: 417-26. PMID 16788928 DOI: 10.1002/lsm.20363 |
0.106 |
|
| 2003 |
Qian Z, Zeitoun NC, Shieh S, Helm T, Oseroff AR. Successful treatment of extramammary Paget's disease with imiquimod. Journal of Drugs in Dermatology : Jdd. 2: 73-6. PMID 12852386 |
0.076 |
|
| 2007 |
Blume JE, Oseroff AR. Aminolevulinic acid photodynamic therapy for skin cancers. Dermatologic Clinics. 25: 5-14. PMID 17126737 DOI: 10.1016/j.det.2006.09.005 |
0.06 |
|
| 2008 |
Cottrell WJ, Paquette AD, Keymel KR, Foster TH, Oseroff AR. Irradiance-dependent photobleaching and pain in delta-aminolevulinic acid-photodynamic therapy of superficial basal cell carcinomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4475-83. PMID 18628462 DOI: 10.1158/1078-0432.CCR-07-5199 |
0.055 |
|
| 2002 |
Delles AM, Rittenhouse-Olson K, Morgan J, Oseroff AR. A simple method for the purification of human peripheral blood antigen presenting cells (dendritic cells, monocytes/macrophages, and B lymphocytes). Immunological Investigations. 31: 233-45. PMID 12472182 |
0.043 |
|
| 2005 |
Oseroff AR, Shieh S, Frawley NP, Cheney R, Blumenson LE, Pivnick EK, Bellnier DA. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy. Archives of Dermatology. 141: 60-7. PMID 15655143 DOI: 10.1001/archderm.141.1.60 |
0.043 |
|
| 2009 |
Wang KK, Cottrell WJ, Mitra S, Oseroff AR, Foster TH. Simulations of measured photobleaching kinetics in human basal cell carcinomas suggest blood flow reductions during ALA-PDT. Lasers in Surgery and Medicine. 41: 686-96. PMID 19802891 DOI: 10.1002/lsm.20847 |
0.028 |
|
| 2007 |
Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass F, Grekin RC, Grichnik JM, Kessinger A, Lee NY, Lessin S, Lydiatt DD, Margolis LW, ... ... Oseroff AR, et al. Basal cell and squamous cell skin cancers. Journal of the National Comprehensive Cancer Network : Jnccn. 5: 506-29. PMID 17509254 |
0.026 |
|
| 2009 |
Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass LF, Grekin RC, Hallahan DE, Kessinger A, Lee NY, Liegeois N, Lydiatt DD, Michalski J, ... ... Oseroff AR, et al. Merkel cell carcinoma. Journal of the National Comprehensive Cancer Network : Jnccn. 7: 322-32. PMID 19401064 |
0.01 |
|
| 2006 |
Miller SJ, Alam M, Andersen J, Berg D, Bichakjian CK, Bowen G, Cheney RT, Glass F, Grekin RC, Grichnik JM, Johnson TM, Kessinger A, Lee NY, Lessin S, Lydiatt DD, ... ... Oseroff AR, et al. Merkel cell carcinoma. Journal of the National Comprehensive Cancer Network : Jnccn. 4: 704-12. PMID 16884672 DOI: 10.6004/JNCCN.2006.0060 |
0.01 |
|
| Hide low-probability matches. |